These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8013402)

  • 21. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models.
    Hastings KL
    Hum Exp Toxicol; 2000 Apr; 19(4):261-5. PubMed ID: 10918520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Tg rasH2 mouse in cancer hazard identification.
    Morton D; Alden CL; Roth AJ; Usui T
    Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
    Mauthe RJ; Gibson DP; Bunch RT; Custer L
    Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.
    Contrera JF; DeGeorge JJ
    Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):71-80. PubMed ID: 9539006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rodent carcinogenicity bioassay: past, present, and future.
    Boorman GA; Maronpot RR; Eustis SL
    Toxicol Pathol; 1994; 22(2):105-11. PubMed ID: 7973358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The carcinogenesis bioassay in perspective: application in identifying human cancer hazards.
    Fung VA; Barrett JC; Huff J
    Environ Health Perspect; 1995; 103(7-8):680-3. PubMed ID: 7588478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009).
    Friedrich A; Olejniczak K
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):225-48. PubMed ID: 21513764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary.
    Cohen SM
    Toxicol Pathol; 2010 Apr; 38(3):487-501. PubMed ID: 20215581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996.
    Gold LS; Manley NB; Slone TH; Rohrbach L
    Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):527-600. PubMed ID: 10421768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of human cancer risk: challenges for alternative approaches.
    Omenn GS
    Toxicol Pathol; 2001; 29 Suppl():5-12. PubMed ID: 11695561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictions for the outcome of rodent carcinogenicity bioassays: identification of trans-species carcinogens and noncarcinogens.
    Tennant RW; Spalding J
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1095-100. PubMed ID: 8933059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database.
    Gold LS; Slone TH; Ames BN
    Drug Metab Rev; 1998 May; 30(2):359-404. PubMed ID: 9606609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride).
    Roberts SM; Jordan KE; Warren DA; Britt JK; James RC
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):44-55. PubMed ID: 11846635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.